ISOWN: Accurate somatic mutation identification in the absence of normal tissue controls

A key step in cancer genome analysis is the identification of somatic mutations in the tumor. This is typically done by comparing the genome of the tumor to the reference genome sequence derived from a normal tissue taken from the same donor.